Investor profile
Neurimmune Holding has backed 1 European tech company across 2 funding rounds between 2018 and 2026, joining rounds totalling €35M. Most active in Healthtech. Data as of 21 Sept 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| NovaGo Therapeutics | Switzerland | 2 | €35M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| NovaGo Therapeutics | Series A | €8.9M | 2019-01 |
